Cleveland Clinic performs first-in-human gene therapy for hypertrophic cardiomyopathy
October 2023, Cleveland: Cleveland Clinic has administered a new gene therapy to deliver a working gene that addresses the main cause of hypertrophic cardiomyopathy (HCM) to the world’s first patient as part of a…
See more Cleveland Clinic performs first-in-human gene therapy for hypertrophic cardiomyopathy